[{"id":"a5b151fc-9227-45c1-95c7-a185934aa520","acronym":"","url":"https://clinicaltrials.gov/study/NCT04658004","created_at":"2021-01-19T20:41:58.819Z","updated_at":"2024-07-02T16:36:37.733Z","phase":"Phase 1","brief_title":"NKG2D CAR-T Cell Therapy for Patients With Relapsed and/or Refractory Acute Myeloid Leukemia","source_id_and_acronym":"NCT04658004","lead_sponsor":"Zhejiang University","biomarkers":" NKG2D","pipe":"","alterations":" ","tags":["NKG2D"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e NKG2D CAR T-cells"],"overall_status":"Not yet recruiting","enrollment":" Enrollment 36","initiation":"Initiation: 01/15/2021","start_date":" 01/15/2021","primary_txt":" Primary completion: 01/15/2024","primary_completion_date":" 01/15/2024","study_txt":" Completion: 01/15/2027","study_completion_date":" 01/15/2027","last_update_posted":"2020-12-08"}]